Acutus Medical, Inc.

NasdaqCM:AFIB Stock Report

Market Cap: US$4.5m

Acutus Medical Past Earnings Performance

Past criteria checks 0/6

Acutus Medical has been growing earnings at an average annual rate of 19.9%, while the Medical Equipment industry saw earnings growing at 11.3% annually. Revenues have been growing at an average rate of 25.9% per year.

Key information

19.9%

Earnings growth rate

87.0%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth rate25.9%
Return on equityn/a
Net Margin-166.4%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Investors Give Acutus Medical, Inc. (NASDAQ:AFIB) Shares A 29% Hiding

Feb 24
Investors Give Acutus Medical, Inc. (NASDAQ:AFIB) Shares A 29% Hiding

Market Cool On Acutus Medical, Inc.'s (NASDAQ:AFIB) Revenues Pushing Shares 43% Lower

Dec 20
Market Cool On Acutus Medical, Inc.'s (NASDAQ:AFIB) Revenues Pushing Shares 43% Lower

Take Care Before Diving Into The Deep End On Acutus Medical, Inc. (NASDAQ:AFIB)

Jul 18
Take Care Before Diving Into The Deep End On Acutus Medical, Inc. (NASDAQ:AFIB)

Acutus files for FDA approval of catheter ablation system AcQBlate

Oct 18

Acutus Medical Non-GAAP EPS of -$0.93 misses by $0.17, revenue of $4.1M beats by $0.13M

Aug 11

Acutus Medical sees Q2 revenue above consensus estimate

Jul 21

Acutus Medical, Inc. (NASDAQ:AFIB) Analysts Just Trimmed Their Revenue Forecasts By 25%

Apr 06
Acutus Medical, Inc. (NASDAQ:AFIB) Analysts Just Trimmed Their Revenue Forecasts By 25%

Acutus Medical: A Name To Slowly Accumulate

Sep 04

Acutus Medical, Inc.: Paradigm-Shifting Technology At A Shocking Price

Jul 21

Acutus Medical cleared to start atrial fibrillation IDE trial

May 27

Analysts Have Been Trimming Their Acutus Medical, Inc. (NASDAQ:AFIB) Price Target After Its Latest Report

May 15
Analysts Have Been Trimming Their Acutus Medical, Inc. (NASDAQ:AFIB) Price Target After Its Latest Report

Revenue & Expenses Breakdown
Beta

How Acutus Medical makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqCM:AFIB Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 237-12143
30 Sep 2320-333624
30 Jun 2318-403825
31 Mar 2317-164326
31 Dec 22329203
30 Sep 2216-865431
30 Jun 2217-946034
31 Mar 2217-1276235
31 Dec 2117-1186437
30 Sep 2115-1166337
30 Jun 2114-1196336
31 Mar 2110-1135635
31 Dec 208-1025033
30 Sep 207-924332
30 Jun 204-933530
31 Mar 204-1003327
31 Dec 193-972723
31 Dec 182-481319

Quality Earnings: AFIB is currently unprofitable.

Growing Profit Margin: AFIB is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: AFIB is unprofitable, but has reduced losses over the past 5 years at a rate of 19.9% per year.

Accelerating Growth: Unable to compare AFIB's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: AFIB is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (2.9%).


Return on Equity

High ROE: AFIB's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.